These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4764148)

  • 1. [Vitiligo in patients with porphyria].
    Guseinov MM
    Vestn Dermatol Venerol; 1973 Jun; 47(6):11-4. PubMed ID: 4764148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems and prospects of vitiligo study].
    Koshevenko IuN; Frolov EP
    Vestn Dermatol Venerol; 1981; (10):25-30. PubMed ID: 6272508
    [No Abstract]   [Full Text] [Related]  

  • 3. The protective role of epidermal melanin in a patient with porphyria variegata and vitiligo.
    Westerhof W; Bebelaar D; Cormane RH; Langelaar J; Hup JM
    Acta Derm Venereol; 1981; 61(1):23-8. PubMed ID: 6164210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current points of view on the therapy of vitiligo].
    Ormea F
    Minerva Med; 1974 Apr; 65(30):1653-64. PubMed ID: 4833771
    [No Abstract]   [Full Text] [Related]  

  • 5. Histopathologic features in vitiligo.
    Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
    Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA synthesis in melanocytes during vitiligo].
    Tschernosemski I; Petkov I; Durmischev A; Zlatkov NB
    Dermatol Monatsschr; 1978 Mar; 164(3):180-5. PubMed ID: 658568
    [No Abstract]   [Full Text] [Related]  

  • 7. Melanocytes are not absent in lesional skin of long duration vitiligo.
    Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
    J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the etiology of vitiligo and gray hair.
    Lerner AB
    Am J Med; 1971 Aug; 51(2):141-7. PubMed ID: 5095523
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcriptional profiling of melanocytes from patients with vitiligo vulgaris.
    Strömberg S; Björklund MG; Asplund A; Rimini R; Lundeberg J; Nilsson P; Pontén F; Olsson MJ
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):162-71. PubMed ID: 18426409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of acetylsalicylic acid on the release rates of leukotrienes B4 and C4 from cultured skin melanocytes of active vitiligo.
    Zailaie MZ
    Saudi Med J; 2004 Oct; 25(10):1439-44. PubMed ID: 15494818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo.
    Kingo K; Aunin E; Karelson M; Rätsep R; Silm H; Vasar E; Kõks S
    J Dermatol Sci; 2008 Oct; 52(1):39-46. PubMed ID: 18514490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.
    Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS
    Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant Notch signaling: a potential pathomechanism of vitiligo.
    Diao JS; Zhang X; Xia WS; Zheng Y; Ren J; Wang YM; Gong Z; Xia W; Guo SZ
    Med Hypotheses; 2009 Jul; 73(1):70-2. PubMed ID: 19269111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A holistic review on the autoimmune disease vitiligo with emphasis on the causal factors.
    Patel S; Rauf A; Khan H; Meher BR; Hassan SSU
    Biomed Pharmacother; 2017 Aug; 92():501-508. PubMed ID: 28575807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis and treatment of vitiligo].
    Borisenko KK
    Vestn Dermatol Venerol; 1973 May; 47(5):11-6. PubMed ID: 4755955
    [No Abstract]   [Full Text] [Related]  

  • 16. Imatinib mesilate inhibits melanogenesis in vitro.
    Cario-André M; Ardilouze L; Pain C; Gauthier Y; Mahon FX; Taieb A
    Br J Dermatol; 2006 Aug; 155(2):493-4. PubMed ID: 16882205
    [No Abstract]   [Full Text] [Related]  

  • 17. [Variegate porphyria; a family study].
    Westerhof W; Smit EM
    Ned Tijdschr Geneeskd; 1981 Aug; 125(31):1235-41. PubMed ID: 7254411
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carbohydrate metabolism disorders in patients with vitiligo].
    Chojnacki J; Kaszuba A; Gajewska B; Dubiecki W
    Przegl Dermatol; 1976; 63(4):455-9. PubMed ID: 968076
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin.
    Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T
    J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pathogenesis of vitiligo].
    Gudzenko ZhP; Kartysh GA; Zaĭchenko KI; Klenus IuN; Korotkaia EV
    Vrach Delo; 1989 Jun; (6):95-8. PubMed ID: 2781779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.